Stock Events

Stock Events

National Graphite 

$0.012000
6
-$0.01-45.45%Monday 20:00

Statistics

Day High
0.0221
Day Low
0.0142
52W High
0.048
52W Low
0.012
Volume
41,800
Avg. Volume
5,171
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Nov 18Expected
Q4 2013
Q1 2014
Q2 2014
Q4 2014
Q4 2014
Q2 2015
Q3 2016
-0.02
-0.02
-0.01
0
Expected EPS
0
Actual EPS
0

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Graphite One
GPHOF
Mkt Cap140.22M
Graphite One Inc. is directly involved in the exploration and development of graphite resources, making it a direct competitor in the graphite market.
Syrah Resources Limited
SYAAF
Mkt Cap204.33M
Syrah Resources is engaged in the production of graphite, competing in the same market for raw materials and customers.
Northern Graphite
NGPHF
Mkt Cap15.77M
NextSource Materials Inc. specializes in the mining and supply of graphite, positioning it as a competitor in the graphite industry.
Brightstar Resources Limited
BTRAF
Mkt Cap542.63M
Battery Minerals Limited is focused on graphite mining and exploration, directly competing for market share in the graphite sector.
Tomra Systems ASA
TMRAY
Mkt Cap2.87B
Triton Minerals Ltd is involved in graphite mining and exploration, competing in the global graphite market.
Seritage Growth Properties
SRG
Mkt Cap101.95M
SRG Mining Inc. specializes in the exploration and development of graphite mines, directly competing in the graphite supply chain.

About

National Graphite Corp. (NGRC), operating through its subsidiary Biotech Development Corp., functions as a biopharmaceutical enterprise specializing in risk and cost-sharing models. The company establishes partnerships with clinical-stage firms dedicated to developing novel biological entities or innovative therapeutic platforms. These collaborations aim to address a wide spectrum of health conditions, encompassing common illnesses, rare disorders, and those with significant unmet medical requirements. Among its key pipeline developments is ELAFIN, a drug candidate identified as a human-identical protein. ELAFIN is being developed specifically for the management of postoperative inflammatory complications. The advancement of ELAFIN is further supported by a collaboration agreement with Proteo Inc. Founded in 2006, National Graphite Corp. was formerly known as Lucky Boy Silver Corporation until it officially adopted its current name in May 2012. The company maintains its operational headquarters in Duesseldorf, Germany.
Show More
CEO
Mrs. Ulrike Dickmann
Employees
1
Country
United States
ISIN
US6362682030

Listings

OTC Link
US
NGRC

0 Comments

Share your thoughts

FAQs

What is National Graphite stock price today?▼
The current price of NGRC is $0.01 USD — it has decreased by -45.45% in the past 24 hours. Watch National Graphite stock price performance more closely on the chart.
What is National Graphite stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange National Graphite stocks are traded under the ticker NGRC.
Is National Graphite stock price growing?▼
NGRC stock has fallen by -45.45% compared to the previous week, the month change is a -62.5% fall, over the last year National Graphite has showed a -33.33% decrease.
What were National Graphite earnings last quarter?▼
NGRC earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does National Graphite have?▼
As of November 1, 2026, the company has 1 employees.
In which sector is National Graphite located?▼
National Graphite operates in the Finance & Payments sector.
When did National Graphite complete a stock split?▼
The last stock split for National Graphite was on August 15, 2014 with a ratio of 1:30.
Where is National Graphite headquartered?▼
National Graphite is headquartered in Las Vegas, United States.